Clinical trial to compare duodenum preserving pancreatic head resection according to Beger versus the Berne modification in patients with chronic pancreatitis: a randomised controlled trial
- Conditions
- Chronic pancreatitisDigestive SystemOther Chronic pancreatitis
- Registration Number
- ISRCTN50638764
- Lead Sponsor
- niversity of Heidelberg Medical School (Germany)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 65
Patients undergoing elective duodenum-preserving pancreatic head resection due to chronic pancreatitis.
Eligibility criteria:
1. Patients of any age (greater than 18 years)
2. Expected survival time more than 24 months
3. Informed consent
1. Participation in another intervention trial that would interfere with the intervention and outcome of this study
2. Severe psychiatric disorders or neurological diseases
3. Lack of compliance
4. Drug and/or alcohol abuse according to local standards
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary endpoint is combined out of four components. In order to adjust for multiple testing a hierarchical model is used.<br><br>1. Duration of surgical procedure [min]<br>2. Quality of life (EORTC QLQ-C30 questionnaire and the disease specific module for pancreatic diseases EORTC QLQ-PAN26) at 12 months after the intervention<br>3. Duration of stay on the intensive care unit<br>4. Duration of postoperative hospital stay
- Secondary Outcome Measures
Name Time Method Frequencies of early and late onset complications such as intra- or postoperative bleeding with subsequent need for blood transfusion, pancreatic fistula, postoperative pulmonary complications, wound infections and re-laparotomy; exocrine and endocrine pancreatic function as determined by levels of HbA1c and stool elastase.<br><br>